Skin Diseases  >>  luminespib (AUY922)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
luminespib (AUY922) / Ligand
NCT01081613 / 2006-002766-20: Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

Completed
N/A
7
Europe
89Zr-bevacizumab PET imaging, 89Zr-bevacizumab
University Medical Center Groningen
Breast Cancer
02/12
02/12

Download Options